DAA Based Therapy for Recently Acquired Hepatitis C (DARE-C)

Clinical trial NCT01743521 · COMPLETED

Trial details

NCT number: NCT01743521
Sponsor: Kirby Institute
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Hepatitis C, Chronic

Start date: 2013-01-01
Primary completion: 2015-11-01
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.